Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori

Lancet. 1997 Jan 4;349(9044):31-2. doi: 10.1016/s0140-6736(05)62165-4.

Authors

W Fischbach¹, W Tacke, A Greiner, H Konrad, Müller-Hermelink

Affiliation

¹ Medical Department II, Klinikum Aschaffenburg, Akademisches Lohrkrankenhaus, Universität Würzburg, Germany.

PMID: 8988128
DOI: 10.1016/s0140-6736(05)62165-4

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Amoxicillin / therapeutic use
Anti-Bacterial Agents / therapeutic use
Anti-Ulcer Agents / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Clarithromycin / therapeutic use
Helicobacter Infections / complications
Helicobacter Infections / drug therapy*
Helicobacter pylori*
Humans
Immunoproliferative Small Intestinal Disease / etiology*
Lymphoma, B-Cell, Marginal Zone / microbiology
Lymphoma, B-Cell, Marginal Zone / therapy
Male
Omeprazole / therapeutic use
Penicillins / therapeutic use

Substances

Anti-Bacterial Agents
Anti-Ulcer Agents
Penicillins
Amoxicillin
Clarithromycin
Omeprazole